ligands acting on targets

1,1,3,3-tetraethoxy-2-methylpropane.

1,1,3,3-tetraethoxy-2-methylpropane.

1,1,3,3-Tetramethyl-1-[2'-(Trimethoxysilyl)Ethyl]-Disiloxane.

1,1,3,3-Tetramethyl-1-[2'-(Trimethoxysilyl)Ethyl]-Disiloxane.

1,1,3,3-Tetramethyl-1-[2'-(Trimethoxysilyl)Ethyl]-Disiloxane.

1,1,3,3-Tetramethyl-1-[2'-(Trimethoxysilyl)Ethyl]-Disiloxane.

1,1,3-Tribromoacetone is an impurity of Methotrexate ( HY-14519 ). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase , thereby preventing the conversion of folic acid into tetrahydrofolate, and

1,1,3-Tribromoacetone is an impurity of Methotrexate ( HY-14519 ). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase , thereby preventing the conversion of folic acid into tetrahydrofolate, and

1,1,3-Tribromoacetone is an impurity of Methotrexate ( HY-14519 ). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase , thereby preventing the conversion of folic acid into tetrahydrofolate, and

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene.

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene.

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene.